Top Markets
Coin of the day
Welgene Biotech Co.,Ltd. Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.

6661
株式のランク #31675
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis... Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
株価
$0.53422367
時価総額
$12.45M
変化(1日)
0.30%
変化(1年)
-19.98%
TW
取引 Welgene Biotech Co.,Ltd. (6661)

カテゴリー

Welgene Biotech Co.,Ltd.(6661)の配当利回りの履歴
Welgene Biotech Co.,Ltd.(銘柄コード: 6661)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Welgene Biotech Co.,Ltd.(6661)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)